|

YL202 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • MediLink Therapeutics (Suzhou) Co., Ltd.1

Indications

  • Locally Advanced or Metastatic Solid Tumors1
  • Colorectal Cancer1
  • Cervical Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other1 trial

A Study of YL202 in Patients With Advanced Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.